Antibodies are essential therapeutic modalities in modern drug development, with applications spanning oncology, autoimmune diseases, infectious diseases, and other therapeutic areas. Their development requires comprehensive evaluation of target binding, Fc receptor interactions, effector functions, pharmacokinetic properties, and biological activity.
As antibody therapeutics become increasingly diverse, reliable cell-based models are essential for characterizing antibody function and supporting candidate screening. To facilitate antibody drug discovery and development, we provide a range of antibody-related engineered cell lines, covering key targets and pathways involved in antibody activity and Fc-mediated functions.
What We Provide
Antibody Expression Cell Lines
•Enable stable and efficient expression of antibody-related targets and receptors
•Support functional studies of FcRn, Fcγ receptors, and other antibody-related proteins
•Facilitate antibody–receptor interaction studies and assay development
•Provide consistent cell models for downstream antibody research
•Suitable for target validation, functional studies, and preclinical research
Antibody Reporter Cell Lines
•Provide sensitive and quantitative readouts of antibody-mediated cellular responses
•Support functional evaluation of Fc receptor-mediated activity and ADCC
•Enable mechanism-based assessment of antibody candidates
•Facilitate antibody potency testing, screening, and comparative evaluation
•Suitable for high-throughput and cell-based functional assays
Together, these engineered cell-based platforms support antibody research across antibody discovery, functional characterization, Fc engineering, ADCC evaluation, pharmacokinetic studies, and preclinical development, providing reliable and reproducible tools to accelerate antibody therapeutic development.
| Product No. | Product Name | Gene | Pre-order/order |
Antibodies are essential therapeutic modalities in modern drug development, with applications spanning oncology, autoimmune diseases, infectious diseases, and other therapeutic areas. Their development requires comprehensive evaluation of target binding, Fc receptor interactions, effector functions, pharmacokinetic properties, and biological activity.
As antibody therapeutics become increasingly diverse, reliable cell-based models are essential for characterizing antibody function and supporting candidate screening. To facilitate antibody drug discovery and development, we provide a range of antibody-related engineered cell lines, covering key targets and pathways involved in antibody activity and Fc-mediated functions.
What We Provide
Antibody Expression Cell Lines
•Enable stable and efficient expression of antibody-related targets and receptors
•Support functional studies of FcRn, Fcγ receptors, and other antibody-related proteins
•Facilitate antibody–receptor interaction studies and assay development
•Provide consistent cell models for downstream antibody research
•Suitable for target validation, functional studies, and preclinical research
Antibody Reporter Cell Lines
•Provide sensitive and quantitative readouts of antibody-mediated cellular responses
•Support functional evaluation of Fc receptor-mediated activity and ADCC
•Enable mechanism-based assessment of antibody candidates
•Facilitate antibody potency testing, screening, and comparative evaluation
•Suitable for high-throughput and cell-based functional assays
Together, these engineered cell-based platforms support antibody research across antibody discovery, functional characterization, Fc engineering, ADCC evaluation, pharmacokinetic studies, and preclinical development, providing reliable and reproducible tools to accelerate antibody therapeutic development.
| Product No. | Product Name | Gene | Pre-order/order |
